Home Details
| Official Symbol of Gene | FGF2 |
| Species | Homo sapiens |
| Entrez Gene ID | 2247 |
| Official Full Name | fibroblast growth factor 2 |
| Also known as | BFGF; FGFB; FGF-2; HBGF-2 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000138685 MIM:134920; AllianceGenome:HGNC:3676 |
| Map Location | 4q28.1 |
| Drug | human broblast growth factor (FGF)-II gene(TH:bFGF vector) |
| Interaction Type | activator |
| Descent | C57BL/6 mice |
| Disease | EAE |
| Pubmed ID | 11509953 |
| Year | 2001 |
| Title | Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice |
| Result | TH:bFGF-treated mice showed a lower number of T cells and macrophages (butalso of inammatory perivascular inltrates) both in theCNS parenchyma and in the leptomeningeal space and a signicant increase of oligoden-drocyte precursors (platelet derived growth factor-receptor α(PDGFRα)+cells) in areas of demyelination andaxonal loss.A signicant decrease of the per-centage of spinal cord demyelination and axonal loss was also observed in TH:bFGF-treated mice. A signicant increase of proteolipidprotein (PLP)-expressing oligodendrocytes was also measured in TH:bFGF-treated mice .Neuropathological ndings indicate that the sustained disease-ameliorating effect observed after the treatment with the TH:bFGF vector was associated with a signi-cant decrease of the extent of CNS demyelination andaxonal loss. |
| Mechanism/pathway | We attribute the disease-ameliorating effect to the FGF-II-mediated recruitment into demyelinating areas of oligodendrocyte precursors located in close vicinity to or surviving within demyelinating lesions which, in turn, differentiated into myelin-forming cells. |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.